AVITA Medical RCEL Cash Flow Statement (2018-2026)

NASDAQ RCEL
$17.30 -0.35 (-1.98%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

AVITA Medical Quarterly Cash Flow Statement

Periods 33 quarters
Latest Sep 2026

AVITA Medical reported cash from operations of -$0.68M and free cash flow of -$0.79M for the quarter ended Sep 2026, up 87.0% year over year. This cash flow statement covers 33 quarters of results from Sep 2018 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-9.46M-6.26M-5.59M-8.87M-9.22M-10.38M-8.71M-7.07M-18.66M-15.39M-16.21M-11.59M-13.86M-9.92M-13.19M-11.62M-10.61M-7.66M-6.22M
Depreciation and DepletionDep. & Depletion
0.13M0.13M0.13M0.10M0.13M0.14M0.16M0.18M0.19M0.19M0.29M0.34M0.39M0.40M0.42M0.40M0.40M0.39M0.37M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.09M0.09M0.09M0.09M0.09M0.09M
Depreciation & Amortization (CF)Dep. & Amort.
-0.21M0.16M0.13M0.13M0.13M0.14M0.15M0.16M0.19M0.20M0.20M0.31M0.41M0.52M0.55M0.57M0.70M0.63M0.61M0.59M
Share-based CompensationStock Comp.
2.93M1.41M1.44M2.31M2.64M1.14M2.43M2.17M2.59M4.03M4.08M2.80M2.69M2.67M2.78M1.37M1.10M1.99M1.67M
Gains from Sales and DivestituresGains Divest
-0.10M-0.08M-0.02M-0.08M-0.01M-0.33M-0.25M-0.01M-0.05M-0.19M-0.09M
Gains from Investment SecuritiesGains Investment
-0.02M
Asset Writedowns and ImpairmentWritedown
-0.32M0.10M0.17M0.07M-0.06M0.08M-0.07M0.39M0.08M0.31M0.23M0.15M0.12M0.06M0.07M0.12M
Other non-cash itemsOther Non-Cash
-0.41M0.21M0.21M0.17M0.17M0.17M1.01M1.08M-1.84M1.01M0.88M-0.16M-0.93M0.20M-0.39M0.87M0.23M2.35M
Change in Working Capital
Change in ReceivablesChange Receivables
-0.49M0.36M0.43M1.16M1.28M0.03M1.70M-0.50M1.65M1.51M1.49M0.25M-1.63M-2.34M0.08M0.80M-0.01M0.50M
Change in InventoryChange Inventory
-0.50M-0.23M0.25M0.75M0.25M1.40M1.29M1.66M-0.31M-0.31M1.12M1.44M-0.63M-0.14M-0.20M-0.75M-0.77M-0.36M
Change in Accrued ExpensesChange Accrued Exp.
-2.45M2.54M-2.96M3.70M-0.22M0.82M-2.17M0.77M3.21M0.68M2.33M-4.84M-2.15M7.40M-1.79M-0.76M-1.64M
Change in Other Operating AssetsOther Assets Change
-7.64M0.37M3.62M-0.29M0.29M1.47M-1.66M1.91M0.00M-0.40M-0.94M-0.61M0.53M0.35M-0.97M0.01M0.78M-0.03M
Change in Other Operating LiabilitiesOther Liabilities Change
0.03M0.73M0.25M-0.91M1.28M0.85M-0.51M-0.19M-1.13M-0.32M2.17M-1.45M0.14M0.01M-0.70M0.60M-0.78M
Other Working Capital ChangesOther WC Changes
7.64M-0.34M-2.89M0.53M-1.20M-0.20M2.51M-2.41M-0.18M-0.73M0.62M2.78M-1.98M-0.22M0.98M-0.72M-0.18M-0.76M
Cash from OperationsCash from Ops.
16.45M-9.37M-5.71M-9.07M-9.10M-8.97M-10.86M-20.86M-12.78M-7.21M-8.04M-10.31M-10.23M-5.22M-5.44M-10.07M-3.53M-0.68M
Investing Activities
Capital ExpendituresCapex
-0.71M0.06M0.25M0.28M0.30M0.50M0.30M1.15M2.65M3.76M1.61M0.22M0.52M0.93M-0.67M0.02M0.11M0.11M
Change in Property, Plant and EquipmentChange in PP&E
0.71M-0.06M-0.25M-0.28M-0.30M-0.50M-0.30M-1.15M-2.65M-3.76M-1.61M-0.22M-0.52M-0.93M0.67M-0.02M-0.11M-0.11M
Change in IntangiblesChange Intangibless
-0.13M0.01M0.02M0.02M0.01M0.01M0.03M0.08M0.00M0.06M0.02M0.01M0.02M0.60M0.00M0.00M
Purchase of InvestmentsInvestments Purchased
25.53M-15.67M5.18M2.45M71.12M2.90M2.92M12.79M5.90M7.89M1.96M3.94M
Sale and Maturity of InvestmentsInvestments Sold
3.00M11.89M24.27M21.12M19.90M14.15M19.20M18.00M24.00M10.00M11.00M11.00M3.50M2.00M6.00M4.00M2.00M
Cash from Investing ActivitiesCash from Investing
-22.60M56.07M18.79M18.36M21.76M-57.30M15.07M12.43M7.39M2.47M10.77M7.02M-5.34M0.01M2.04M3.89M1.89M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
49.08M
Long-Term Debt RepaymentsLT Debt Repayment
Net Long-Term Debt Issued (Repaid)Net LT Debt
49.08M
Net Debt Issuances and RepaymentsNet Debt Issuance
49.08M
Change in Capital Stock
Common Stock IssuedStock Issued
0.00M0.90M0.17M0.17M0.60M0.02M0.63M0.06M1.01M0.43M0.36M0.01M14.82M0.00M0.18M
Net Shares Issued and RepurchasedNet Shares Issued
0.00M0.90M0.17M0.17M0.60M0.02M0.63M0.06M1.01M0.43M0.36M0.01M14.82M0.00M0.18M
Net Equity Issued and RepurchasedNet Equity Issued
0.00M0.90M0.17M0.17M0.60M0.02M0.63M0.06M1.01M0.43M0.36M0.01M14.82M0.00M0.18M
Other financing activities (as filed)
-1.06M-0.40M
Cash from Financing ActivitiesCash from Financing
-64.01M0.00M0.90M0.17M0.17M0.60M39.43M0.63M0.85M1.01M1.02M0.36M0.56M13.77M0.25M6.10M0.44M0.18M
Additional items
Exchange Rate EffectFX Effect
-0.20M-0.01M0.04M0.00M0.00M-0.02M0.00M
Change in Cash
-96.48M-31.98M50.34M9.89M9.44M13.37M-28.74M-5.17M0.50M1.19M-4.59M0.82M-2.65M3.21M-5.18M-1.93M0.83M1.36M
Ending Cash Balance
55.71M23.74M34.94M23.82M18.16M28.05M37.49M50.85M22.12M16.95M17.45M18.64M14.05M14.87M12.22M15.42M10.24M8.31M9.14M10.50M
Free Cash FlowFCF
17.16M-9.43M-5.96M-9.36M-9.40M-9.48M-11.16M-22.01M-15.43M-10.97M-9.65M-10.53M-10.75M-6.15M-4.77M-10.09M-3.64M-0.79M
Net Cash FlowNCF
-47.56M-31.97M51.25M9.89M9.43M13.39M-28.74M-5.17M0.50M1.19M-4.55M0.82M-2.65M3.21M-5.18M-1.93M0.80M1.39M
Interest Paid
0.01M0.01M4.000.01M0.01M1.12M1.36M1.35M1.36M1.30M1.23M1.25M1.26M1.24M1.42M1.45M1.47M
Income Taxes PaidTaxes Paid
-0.03M9.000.04M0.02M0.00M0.00M0.02M0.00M

AVITA Medical Cash Flow Statement API

Pull AVITA Medical's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RCEL&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY